Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …

Similarities have been reported between the diagnostic and associated characteristics of
binge-eating disorder (BED) and substance-related and non-substance-related disorders …

Aims Substance use disorders (SUD) are associated with cognitive deficits that are not
always addressed in current treatments, and this hampers recovery. Cognitive training and …

Background Stimulant‐related overdoses have increased dramatically, with almost 50% of
overdoses in the United States now involving stimulants. Additionally, harm‐reduction …

Background Animal-borne telemetry instruments (tags) have greatly advanced our
understanding of species that are challenging to observe. Recently, non-recoverable …

Background and aims Approach bias modification (ApBM) targeting alcohol approach bias
has been previously shown to reduce likelihood of relapse during the first 2 weeks following …

Abstract Background and Aims Substance use disorders (SUDs) affect approximately 40.3
million people in the USA, yet only approximately 19% receive evidence-based treatment …

Background Medication for opioid use disorder (MOUD) is an effective intervention to
combat opioid use disorder and overdose, yet there is limited understanding of engagement …

Introduction Services to treat problematic alcohol use (PAU) should be highly accessible to
optimize treatment engagement. We conducted a scoping review to map characteristics of …

Introduction Reward deficits negatively impact recovery from substance use disorder (SUD).
LETS ACT, a behavioral activation treatment targeting substance-free reward, has …